DE-LYCRA
The LYCRA Company , a global leader in developing innovative solutions for the textile, apparel, and personal care industries, today introduced a breakthrough LYCRA® FitSense™ technology innovation that reduces or eliminates the need for bra foam. This patent-pending bra cup application can be used in intimate apparel such as traditional wired, non-wired or unlined bras (including bralettes and sport bras), plus activewear and swimwear.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210727005390/en/
LYCRA® FitSense™ technology is a water-based, solvent-free dispersion that is comprised of the same molecule as LYCRA® fiber. The dispersion is screen-printed directly onto the bra fabric, increasing the power of the fabric in precise areas. The power increase in the bra cup effectively reduces nipple protrusion while providing symmetrical support, shaping and lift for the bustline—reducing or eliminating the need for sewn-in panels or insertable pads.
Zones of support can be applied to the bottom and sides of the bra cup for shaping, as well as the wing for maximum comfort and smoothing. LYCRA® FitSense™ technology also can be applied between fabric layers in the bra cup to mask nipple protrusion while retaining the original fabric aesthetics.
“With LYCRA® FitSense™ technology, the print does the work of the pad and enables brands to build a better bra for all sizes, styles and silhouettes—a true breakthrough development,” said Melissa Stewart, global technology director-R&D materials innovations. “With this new innovation, women have more choices in bras that provide functionality, style and comfort.”
Bras can be rigid, bulky, and hot, with multiple components and structures creating an uncomfortable, restrictive wearing experience. LYCRA® FitSense™ technology can be used to design functional bras that are lighter, thinner, and more breathable, without sacrificing modesty, all-day comfort, durability, support or shaping. And unlike polyurethane foam—which discolors and can move around or even get lost in the wash—LYCRA® FitSense™ technology is built into the garment and is highly durable to machine washing and regular wear. Further, in swimwear applications, the technology provides chlorine resistance and fast drying benefits versus foams and dual fabric layers.
LYCRA® FitSense™ technology offers intimate apparel makers versatility to create intentional design aesthetics by incorporating delicate patterns and artistic details that align with their brand identities. “Designs and colors can be easily customized to deliver on-trend fashion cues—from feminine, lacelike designs to sporty geometric shapes—that satisfy all tastes,” said Stewart. “With LYCRA® FitSense™ technology, a designer’s imagination is the only creative limitation.”
LYCRA® FitSense™ technology, which achieved the ECO PASSPORT by OEKO-TEX® sustainability certification, is applied using standard screen-printing processes, eliminating the need for specialty equipment or major supply chain upgrades. The LYCRA Company provides technical guidance to enable brands, retailers, and garment makers to easily access this innovation.
For more information, download our white paper on the LYCRA FitSense™ technology and screen-printed bra cup application.
About The LYCRA Company
The LYCRA Company innovates and produces fiber and technology solutions for the apparel and personal care industries. Headquartered in Wilmington, Delaware, The LYCRA Company is recognized worldwide for its innovative products, technical expertise, sustainable solutions, and unmatched marketing support. The LYCRA Company owns leading consumer and trade brands: LYCRA® , LYCRA HyFit® , LYCRA® T400® , COOLMAX® , THERMOLITE® , ELASPAN® , SUPPLEX® , and TACTEL® . The LYCRA Company’s legacy stretches back to 1958 with the invention of the original spandex yarn, LYCRA® fiber. Today, The LYCRA Company focuses on adding value to its customers’ products by developing unique innovations designed to meet the consumer’s need for comfort and lasting performance. For more information, visit www.thelycracompany.com .
LYCRA® FitSense™ is a trademark of The LYCRA Company.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210727005390/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Outpost24 Secures New Investment to Scale its Exposure Management and Identity Security Solutions17.12.2025 08:00:00 CET | Press release
The strategic funding from international investment firm Vitruvian Partners will advance the company’s platform, helping organizations rapidly transform threat data into decisive action and a more robust security posture. Outpost24, a leader in exposure management and identity security, today announced a new investment from Vitruvian Partners to fuel its next phase of global growth. This significant new funding will accelerate innovation across the company's platform, with a focus on integrating AI capabilities to optimize how security teams identify and neutralize critical vulnerabilities. The only European vendor recognized as an overall leader in the 2025 KuppingerCole Leadership Compass Report for Attack Surface Management, Outpost24 delivers a distinct approach to cyber defence that empowers security teams to gain a complete understanding of their digital and human risk landscape. Last week, Outpost24 announced the acquisition of Infinipoint, a specialist in device identity, postu
VeritasChain Unveils VAP Architecture, New Auditability Research, and Confirms Submissions to 58 Regulators Globally17.12.2025 08:00:00 CET | Press release
VeritasChain today unveiled its Verifiable AI Provenance Framework (VAP) architecture, published new research on verifiable audit trails, and confirmed informational submissions to 58 regulatory authorities across 43 jurisdictions. These milestones advance VeritasChain’s mission to establish a global framework for verifiable auditability in AI and algorithmic trading. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251216433807/en/ Map indicates jurisdictions where regulatory outreach or informational submissions have been made as of Dec 2025. Verifiable AI Provenance Framework (VAP) VAP is a layered assurance architecture designed for independent verification of AI decision-making. It is not a single product, but a framework defining how cryptographic evidence and third-party verification interoperate across diverse systems. The architecture records decision-to-execution events as immutable audit trails, facilitating regulat
New Published Data Confirms Nemluvio® (Nemolizumab) Can Rapidly Relieve Itch and Improve Sleep in as Early as Two Days in Both Atopic Dermatitis and Prurigo Nodularis17.12.2025 07:00:00 CET | Press release
Post-hoc analyses of the phase III ARCADIA and OLYMPIA clinical trial programs, published in the Journal of the European Academy of Dermatology and Venereology, highlight nemolizumab’s fast onset of action and improvement of itch and sleep disturbance in patients with moderate-to-severe atopic dermatitis and prurigo nodularis1 Significant improvements in itch were observed as early as 48 hours after initial treatment and steadily increased through to Day 141 Nemolizumab is the first approved monoclonal antibody that specifically targets and inhibits the signalling of IL-31 – a neuroimmune cytokine that drives itch and other symptoms in atopic dermatitis and prurigo nodularis2-4 Nemolizumab is approved by multiple regulatory authorities around the world for the treatment of moderate-to-severe atopic dermatitis and prurigo nodularis, including in the U.S. and EU5,6 Galderma (SIX: GALD), the pure-play dermatology category leader, today released new clinical data confirming nemolizumab’s r
Mori Memorial Foundation’s Global Power City Index 2025 Sees City Rankings Shift Due to Tourism Gains in East Asia and Inflationary Pressures in the West17.12.2025 04:00:00 CET | Press release
The Mori Memorial Foundation’s Institute for Urban Strategies, a research body established by Mori Building, Tokyo’s leading urban landscape developer, today published its annual Global Power City Index (GPCI) 2025, a report evaluating the urban competitiveness of 48 major cities worldwide. The report also includes the GPCI–Financial Centers index, an assessment of cities as international financial centers, and the new GPCI–Startup Ecosystems index, which assesses the competitiveness of startup environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251216187692/en/ 48 Major Cities Evaluated in Mori Memorial Foundation’s GPCI-2025 Report This year’s report highlights the remarkable rise of East Asian cities and the stagnation of several Western cities, showing how global challenges, such as geopolitical tensions and regional disparities in inflation, are greatly impacting the performance of major cities worldwide. The r
GE HealthCare and Indonesia’s Ministry of Health to expand access to quality care through the provision of 300+ advanced CT scanners17.12.2025 03:00:00 CET | Press release
300+ advanced CT scanners to be installed in public hospitals across 38 provinces by 2028, to support early diagnosis and treatment of non-communicable diseases. Collaboration supports Indonesian Government’s agenda to enhance diagnostic access and build national healthcare resilience. Multi-year agreement builds on GE HealthCare’s continued investment in local manufacturing, capability building and knowledge transfer to strengthen Indonesia’s healthcare ecosystem. GE HealthCare (Nasdaq: GEHC) today announced it will supply more than 300 CT (computed tomography) scanners under Indonesia’s Strengthening Indonesia’s Health Referral Network (SIHREN) program to deliver equitable, high-quality care to more than 280 million Indonesians. As part of a competitively awarded, multi-year contract, GE HealthCare will supply the advanced CT scanners to public hospitals across all 38 provinces, including urban and remote areas. The CT scanner procurement under SIHREN was conducted through a fully co
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom